SEMLER SCIENTIFIC INC (SMLR) Fundamental Analysis & Valuation

NASDAQ:SMLR • US81684M1045

Current stock price

20.33 USD
-1.04 (-4.87%)
At close:
20.33 USD
0 (0%)
After Hours:

This SMLR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SMLR Profitability Analysis

1.1 Basic Checks

  • SMLR had positive earnings in the past year.
  • SMLR had a negative operating cash flow in the past year.
  • In the past 5 years SMLR has always been profitable.
  • Each year in the past 5 years SMLR had a positive operating cash flow.
SMLR Yearly Net Income VS EBIT VS OCF VS FCFSMLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 8.10%, SMLR belongs to the top of the industry, outperforming 89.25% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 10.51%, SMLR belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
Industry RankSector Rank
ROA 8.1%
ROE 10.51%
ROIC N/A
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
SMLR Yearly ROA, ROE, ROICSMLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800 1K

1.3 Margins

  • SMLR has a better Profit Margin (130.80%) than 99.46% of its industry peers.
  • SMLR's Profit Margin has improved in the last couple of years.
  • In the last couple of years the Operating Margin of SMLR has grown nicely.
  • SMLR has a better Gross Margin (90.83%) than 97.31% of its industry peers.
  • SMLR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 130.8%
GM 90.83%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
SMLR Yearly Profit, Operating, Gross MarginsSMLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

3

2. SMLR Health Analysis

2.1 Basic Checks

  • SMLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SMLR has been increased compared to 1 year ago.
  • Compared to 5 years ago, SMLR has more shares outstanding
  • There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SMLR Yearly Shares OutstandingSMLR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMLR Yearly Total Debt VS Total AssetsSMLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • SMLR has an Altman-Z score of 1.72. This is a bad value and indicates that SMLR is not financially healthy and even has some risk of bankruptcy.
  • SMLR has a Altman-Z score of 1.72. This is comparable to the rest of the industry: SMLR outperforms 55.91% of its industry peers.
  • A Debt/Equity ratio of 0.25 indicates that SMLR is not too dependend on debt financing.
  • SMLR's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. SMLR outperforms 54.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z 1.72
ROIC/WACCN/A
WACC10%
SMLR Yearly LT Debt VS Equity VS FCFSMLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.97 indicates that SMLR should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.97, SMLR is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
  • SMLR has a Quick Ratio of 1.95. This is a normal value and indicates that SMLR is financially healthy and should not expect problems in meeting its short term obligations.
  • SMLR's Quick ratio of 1.95 is in line compared to the rest of the industry. SMLR outperforms 54.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.95
SMLR Yearly Current Assets VS Current LiabilitesSMLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

4

3. SMLR Growth Analysis

3.1 Past

  • SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 220.88%, which is quite impressive.
  • The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
  • SMLR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.30%.
  • Measured over the past years, SMLR shows a quite strong growth in Revenue. The Revenue has been growing by 11.43% on average per year.
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%

3.2 Future

  • The Earnings Per Share is expected to decrease by -29.01% on average over the next years. This is quite bad
  • Based on estimates for the next years, SMLR will show a very negative growth in Revenue. The Revenue will decrease by -16.29% on average per year.
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SMLR Yearly Revenue VS EstimatesSMLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
SMLR Yearly EPS VS EstimatesSMLR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

4

4. SMLR Valuation Analysis

4.1 Price/Earnings Ratio

  • SMLR is valuated cheaply with a Price/Earnings ratio of 2.32.
  • Based on the Price/Earnings ratio, SMLR is valued cheaper than 99.46% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of SMLR to the average of the S&P500 Index (27.66), we can say SMLR is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 249.14, SMLR can be considered very expensive at the moment.
  • SMLR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SMLR is cheaper than 65.05% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SMLR to the average of the S&P500 Index (38.00), we can say SMLR is valued expensively.
Industry RankSector Rank
PE 2.32
Fwd PE 249.14
SMLR Price Earnings VS Forward Price EarningsSMLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SMLR Per share dataSMLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • SMLR has a very decent profitability rating, which may justify a higher PE ratio.
  • A cheap valuation may be justified as SMLR's earnings are expected to decrease with -29.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%

0

5. SMLR Dividend Analysis

5.1 Amount

  • SMLR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SMLR Fundamentals: All Metrics, Ratios and Statistics

SEMLER SCIENTIFIC INC

NASDAQ:SMLR (1/15/2026, 8:17:24 PM)

After market: 20.33 0 (0%)

20.33

-1.04 (-4.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)02-16
Inst Owners65.81%
Inst Owner Change-0.02%
Ins Owners4.75%
Ins Owner Change0%
Market Cap308.20M
Revenue(TTM)36.96M
Net Income(TTM)48.34M
Analysts82.22
Price Target66.98 (229.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1964.05%
Min EPS beat(2)1930.07%
Max EPS beat(2)1998.04%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.59%
Min Revenue beat(2)-6.63%
Max Revenue beat(2)-0.56%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-12.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 2.32
Fwd PE 249.14
P/S 8.34
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB N/A
EV/EBITDA N/A
EPS(TTM)8.76
EY43.09%
EPS(NY)0.08
Fwd EY0.4%
FCF(TTM)-1.79
FCFYN/A
OCF(TTM)-1.78
OCFYN/A
SpS2.44
BVpS30.33
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)0.1
Graham Number77.3133 (280.29%)
Profitability
Industry RankSector Rank
ROA 8.1%
ROE 10.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 130.8%
GM 90.83%
FCFM N/A
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.77%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.95
Altman-Z 1.72
F-Score2
WACC10%
ROIC/WACCN/A
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)220.88%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%48.61%
EPS Next Y-95.59%
EPS Next 2Y-87.87%
EPS Next 3Y-29.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-37.3%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-44.56%
Revenue Next Year-43.2%
Revenue Next 2Y-30.37%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-126.25%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-354.87%
EBIT Next 3Y-51.48%
EBIT Next 5YN/A
FCF growth 1Y-262.46%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-244.7%
OCF growth 3Y14.98%
OCF growth 5Y13.91%

SEMLER SCIENTIFIC INC / SMLR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SEMLER SCIENTIFIC INC (SMLR) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SMLR.


What is the valuation status of SEMLER SCIENTIFIC INC (SMLR) stock?

ChartMill assigns a valuation rating of 4 / 10 to SEMLER SCIENTIFIC INC (SMLR). This can be considered as Fairly Valued.


Can you provide the profitability details for SEMLER SCIENTIFIC INC?

SEMLER SCIENTIFIC INC (SMLR) has a profitability rating of 6 / 10.


What is the valuation of SEMLER SCIENTIFIC INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SEMLER SCIENTIFIC INC (SMLR) is 2.32 and the Price/Book (PB) ratio is 0.67.


How financially healthy is SEMLER SCIENTIFIC INC?

The financial health rating of SEMLER SCIENTIFIC INC (SMLR) is 3 / 10.